Dying for insulin in the USA
Business Daily
00:00
The High Cost of Insulin in the USA
This chapter delves into the complex and opaque pricing of insulin in the USA, attributing high costs to pharmaceutical companies, insurance entities, and middlemen in the supply chain. It highlights the struggles of uninsured diabetes patients who face financial burden and questions the role of insurance companies in setting prices. The debate on whether selling medications like insulin directly to consumers would be more cost-effective is also explored.
Play episode from 04:44
Transcript
